CARGO THERAPEUTICS INC (CRGX) Stock Price, Quote, News and Overview
NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD
CRGX Quote, Performance and Key Statistics
3.76
+0.12 (+3.3%)
The current stock price of CRGX is 3.76 USD. In the past month the price increased by 10.91%. In the past year, price decreased by -85%.
CRGX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.66 | 369.39B | ||
| AMGN | AMGEN INC | 15.54 | 165.43B | ||
| GILD | GILEAD SCIENCES INC | 24.8 | 142.43B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1654.45 | 123.26B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.31 | 76.39B | ||
| ARGX | ARGENX SE - ADR | 242.12 | 37.96B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.83B | ||
| ONC | BEIGENE LTD-ADR | N/A | 29.00B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.07B | ||
| NTRA | NATERA INC | N/A | 20.54B | ||
| BIIB | BIOGEN INC | 8.53 | 20.47B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.26B |
Related stock screener links
About CRGX
Company Profile
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 116 full-time employees. The company went IPO on 2023-11-10. The firm is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chimeric antigen receptor (CAR) T-cell therapies. The CAR is a protein that has been engineered to modify T cells so they can recognize and destroy cancer cells. The Company’s lead program, firicabtagene autoleucel (CRG-022), is an autologous (derived from a patient’s cells) CD22 CAR T-cell product candidate. The firm is also engaged in evaluating CRG-022 in patients at earlier stages of disease, including large B-cell lymphoma (LBCL) and other hematologic malignancies. The firm is also leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic designed by the Company to enhance CAR T-cell persistence and trafficking to tumor lesions.
Company Info
CARGO THERAPEUTICS INC
835 Industrial Road, Suite 400
San Carlos CALIFORNIA US
Employees: 150
Company Website: https://cargo-tx.com
Investor Relations: http://cargo-tx.com/about/investors/
Phone: 16504998950
CARGO THERAPEUTICS INC / CRGX FAQ
What is the stock price of CARGO THERAPEUTICS INC today?
The current stock price of CRGX is 3.76 USD. The price increased by 3.3% in the last trading session.
What is the ticker symbol for CARGO THERAPEUTICS INC stock?
The exchange symbol of CARGO THERAPEUTICS INC is CRGX and it is listed on the Nasdaq exchange.
On which exchange is CRGX stock listed?
CRGX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CARGO THERAPEUTICS INC stock?
14 analysts have analysed CRGX and the average price target is 12.92 USD. This implies a price increase of 243.62% is expected in the next year compared to the current price of 3.76. Check the CARGO THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CARGO THERAPEUTICS INC worth?
CARGO THERAPEUTICS INC (CRGX) has a market capitalization of 173.07M USD. This makes CRGX a Micro Cap stock.
How many employees does CARGO THERAPEUTICS INC have?
CARGO THERAPEUTICS INC (CRGX) currently has 150 employees.
What are the support and resistance levels for CARGO THERAPEUTICS INC (CRGX) stock?
CARGO THERAPEUTICS INC (CRGX) has a support level at 3.38 and a resistance level at 3.91. Check the full technical report for a detailed analysis of CRGX support and resistance levels.
Should I buy CARGO THERAPEUTICS INC (CRGX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CRGX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CRGX, evaluating the profitability, health, valuation and growth aspects
- CARGO THERAPEUTICS INC (CRGX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CARGO THERAPEUTICS INC (CRGX) Sales and EPS estimates to see what analysts future expectations are.
- CARGO THERAPEUTICS INC (CRGX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CARGO THERAPEUTICS INC (CRGX) Insider and Institutional Ownership to learn about the owners and their transactions.
- CARGO THERAPEUTICS INC (CRGX) Stock Chart to make your own analysis
- CARGO THERAPEUTICS INC (CRGX) Latest news and press-releases to stay up to date.
Does CARGO THERAPEUTICS INC (CRGX) stock pay dividends?
CRGX does not pay a dividend.
When does CARGO THERAPEUTICS INC (CRGX) report earnings?
CARGO THERAPEUTICS INC (CRGX) will report earnings on 2025-03-21, after the market close.
What is the Price/Earnings (PE) ratio of CARGO THERAPEUTICS INC (CRGX)?
CARGO THERAPEUTICS INC (CRGX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.26).
What is the Short Interest ratio of CARGO THERAPEUTICS INC (CRGX) stock?
The outstanding short interest for CARGO THERAPEUTICS INC (CRGX) is 10.75% of its float. Check the ownership tab for more information on the CRGX short interest.
CRGX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CRGX. When comparing the yearly performance of all stocks, CRGX is a bad performer in the overall market: 99.2% of all stocks are doing better.
CRGX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CRGX. No worries on liquidiy or solvency for CRGX as it has an excellent financial health rating, but there are worries on the profitability.
CRGX Financial Highlights
Over the last trailing twelve months CRGX reported a non-GAAP Earnings per Share(EPS) of -4.26. The EPS decreased by -124.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -34.18% | ||
| ROE | -38.45% | ||
| Debt/Equity | 0 |
CRGX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 53% to CRGX. The Buy consensus is the average rating of analysts ratings from 14 analysts.